These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2871652)

  • 21. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
    Ilbäck NG; Siller M; Stålhandske T
    Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Caffeine. Physiological and pharmacological aspects].
    Nørager CB; Jensen MB; Madsen MR
    Ugeskr Laeger; 2004 May; 166(22):2138-42. PubMed ID: 15222164
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxicity of inorganic arsenic salts.
    Winship KA
    Adverse Drug React Acute Poisoning Rev; 1984; 3(3):129-60. PubMed ID: 6397979
    [No Abstract]   [Full Text] [Related]  

  • 24. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity.
    Forsby A; Blaauboer B
    Hum Exp Toxicol; 2007 Apr; 26(4):333-8. PubMed ID: 17615114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine as a psychomotor stimulant: mechanism of action.
    Fisone G; Borgkvist A; Usiello A
    Cell Mol Life Sci; 2004 Apr; 61(7-8):857-72. PubMed ID: 15095008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine enhances the calcium-dependent cardiac mitochondrial permeability transition: relevance for caffeine toxicity.
    Sardão VA; Oliveira PJ; Moreno AJ
    Toxicol Appl Pharmacol; 2002 Feb; 179(1):50-6. PubMed ID: 11884236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine.
    van Vliet E; Morath S; Eskes C; Linge J; Rappsilber J; Honegger P; Hartung T; Coecke S
    Neurotoxicology; 2008 Jan; 29(1):1-12. PubMed ID: 18023877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human disposition and some biochemical aspects of methylxanthines.
    Yesair DW; Branfman AR; Callahan MM
    Prog Clin Biol Res; 1984; 158():215-33. PubMed ID: 6396646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
    Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
    J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over the limit? Americans young and old crave high-octane fuel, and doctors are jittery.
    Shute N
    US News World Rep; 2007 Apr; 142(14):60-2, 65-8. PubMed ID: 17477331
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased emotional reactivity in rats following exposure to caffeine during adolescence.
    Anderson NL; Hughes RN
    Neurotoxicol Teratol; 2008; 30(3):195-201. PubMed ID: 18378115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-specific differences on caffeine consumption and chronic stress-induced anxiety-like behavior and DNA breaks in the hippocampus.
    Noschang CG; Pettenuzzo LF; von Pozzer Toigo E; Andreazza AC; Krolow R; Fachin A; Avila MC; Arcego D; Crema LM; Diehl LA; Gonçalvez CA; Vendite D; Dalmaz C
    Pharmacol Biochem Behav; 2009 Nov; 94(1):63-9. PubMed ID: 19635494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in frequency of fetopathic effects of caffeine in mice by pretreatment with propranolol.
    Fujii T; Nishimura H
    Teratology; 1974 Oct; 10(2):149-52. PubMed ID: 4473845
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata.
    Quinn B; Gagné F; Blaise C
    Sci Total Environ; 2009 Jan; 407(3):1072-9. PubMed ID: 19013635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine, cycling performance, and exogenous CHO oxidation: a dose-response study.
    Desbrow B; Barrett CM; Minahan CL; Grant GD; Leveritt MD
    Med Sci Sports Exerc; 2009 Sep; 41(9):1744-51. PubMed ID: 19657295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiating effects of caffeine on teratogenicity of alkylating agents in mice.
    Fujii T; Nakatsuka T
    Teratology; 1983 Aug; 28(1):29-33. PubMed ID: 6415842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeine--its identity, dietary sources, intake and biological effects.
    Graham DM
    Nutr Rev; 1978 Apr; 36(4):97-102. PubMed ID: 353595
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of toxicological studies on praziquantel.
    Frohberg H
    Arzneimittelforschung; 1984; 34(9B):1137-44. PubMed ID: 6542381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit.
    Beach CA; Mays DC; Sterman BM; Gerber N
    J Pharmacol Exp Ther; 1985 Apr; 233(1):18-23. PubMed ID: 3981454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.